TrialJournal of managed care & specialty pharmacy2024
Within-trial hospitalization resource utilization and budget impact analysis for darolutamide in metastatic hormone-sensitive prostate cancer using ARASENS.
Alicia K Morgans et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.